Detalhe da pesquisa
1.
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1.
Nat Chem Biol
; 17(7): 776-783, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33859413
2.
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.
Mol Pharm
; 18(9): 3464-3474, 2021 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448393
3.
Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1.
Biol Chem
; 399(9): 1091-1097, 2018 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29447112
4.
The Australasian Cell Death Society (ACDS): celebrating 50 years of Australasian cell death research.
Immunol Cell Biol
; 100(1): 9-14, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761822
5.
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.
Theranostics
; 12(16): 6915-6930, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36276654
6.
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention.
Cancer Res
; 81(9): 2259-2269, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33509939
7.
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer.
Contrast Media Mol Imaging
; 2021: 3153278, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621145
8.
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.
Cancers (Basel)
; 13(18)2021 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572879
9.
Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation.
Front Oncol
; 10: 592455, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33224887
10.
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer.
Theranostics
; 10(5): 2095-2114, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32104500
11.
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.
Theranostics
; 10(9): 4116-4133, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32226543
12.
Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.
Cancers (Basel)
; 12(4)2020 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32260077